glp 1 agonist diabetes How GLP-1 Receptor Agonists Evolved from to Weight Loss Treatments Evolution of GLP‐1 Receptor Agonists
Description
There was a reduction in plasma glucose and HbA1c levels at the three highest doses of retatrutide and a dose-dependent reduction in body weight [63]
Going forward, the trajectory of this market will depend on how effectively stakeholders balance accessibility with safety, innovation with regulation, and affordability with quality
Ferreiro E, Lanzillo M, Canhoto D, et al
Common side effects include: Gastrointestinal issues: Nausea (15-20%), vomiting (5-9%), diarrhea (8%), stomach pain (6-7%), and constipation (3-7%) Mild discomfort: Headache, dizziness, fatigue, bloating, gas, or heartburn Appetite changes: Some individuals report loss of appetite Most side effects are temporary and improve over time
doi: 10.1038/nm.3997 149 NamKoongCKimMSJangBTLeeYHChoYMChoiHJ
